{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T16:25:37Z","timestamp":1748535937534,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["4670","4670","4670","4670","4670","4670","4670","4670","4670"],"award-info":[{"award-number":["4670","4670","4670","4670","4670","4670","4670","4670","4670"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>We aimed to characterize the proportion of clients presenting to community pharmacies with influenza-like illness (ILI) and the severity of their illness; the proportion with detectable influenza A, influenza B, and other pathogens (i.e., parainfluenza I, II, and III, adenovirus, respiratory syncytial virus, human metapneumovirus); and to describe their self-medication practices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was conducted in six pharmacies in Guatemala City. Study personnel collected nasopharyngeal and oropharyngeal swabs from participants who met the ILI case definition and who were self-medicating for the current episode. Participants were tested for influenza A and B and other pathogens using real-time RT-PCR. Participants\u2019 ILI-associated self-medication practices were documented using a questionnaire.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of all patients entering the pharmacy during peak hours who responded to a screening survey (<jats:italic>n<\/jats:italic>\u2009=\u200918,016) 6% (<jats:italic>n<\/jats:italic>\u2009=\u20091029) self-reported ILI symptoms, of which 45% (<jats:italic>n<\/jats:italic>\u2009=\u2009470\/1029) met the study case definition of ILI. Thirty-one percent (148\/470) met inclusion criteria, of which 87% (130\/148) accepted participation and were enrolled in the study. Among 130 participants, nearly half tested positive for viral infection (<jats:italic>n<\/jats:italic>\u2009=\u200955, 42.3%) and belonged to groups at low risk for complications from influenza. The prevalence of influenza A was 29% (<jats:italic>n<\/jats:italic>\u2009=\u200935). Thirteen percent of the study population (<jats:italic>n<\/jats:italic>\u2009=\u200917) tested positive for a respiratory virus other than influenza. Sixty-four percent of participants (<jats:italic>n<\/jats:italic>\u2009=\u200983) reported interest in receiving influenza vaccination if it were to become available in the pharmacy. Medications purchased included symptom-relieving multi-ingredient cold medications (<jats:italic>n<\/jats:italic>\u2009=\u200943\/100, 43%), nonsteroidal anti-inflammatory drugs (<jats:italic>n<\/jats:italic>\u2009=\u200923, 23%), and antibiotics (<jats:italic>n<\/jats:italic>\u2009=\u200916, 16%). Antibiotic use was essentially equal among antibiotic users regardless of viral status. The broad-spectrum antibiotics ceftriaxone and azithromycin were the most common antibiotics purchased.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>During a typical influenza season, a relatively low proportion of all pharmacy visitors were experiencing influenza symptoms. A high proportion of clients presenting to pharmacies with ILI tested positive for a respiratory virus. Programs that guide appropriate use of antibiotics in this population are needed and become increasingly important during pandemics caused by respiratory viral pathogens.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-13962-8","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T01:02:34Z","timestamp":1660352554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Self-medication and ILI etiologies among individuals presenting at pharmacies with influenza-like illness: Guatemala City, 2018 influenza season"],"prefix":"10.1186","volume":"22","author":[{"given":"Brooke M.","family":"Ramay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Jara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Purificaci\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P.","family":"Alvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Sofia","family":"Arriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vic","family":"Veguilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Cornelia","family":"Kaydos-Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"key":"13962_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3201\/eid2407.171270","volume":"24","author":"J Bresee","year":"2018","unstructured":"Bresee J, Fitzner J, Campbell H, Cohen C, Cozza V, Jara J, et al. Progress and remaining gaps in estimating the global disease burden of influenza. Emerg Infect Dis. 2018;24:1173\u20137.","journal-title":"Emerg Infect Dis"},{"key":"13962_CR2","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","volume":"25","author":"N-AM Molinari","year":"2007","unstructured":"Molinari N-AM, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086\u201396.","journal-title":"Vaccine"},{"key":"13962_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.japh.2015.11.008","volume":"56","author":"ME Klepser","year":"2016","unstructured":"Klepser ME, Klepser DG, Dering-Anderson AM, Morse JA, Smith JK, Klepser SA. Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness. J Am Pharm Assoc. 2016;56:14\u201321.","journal-title":"J Am Pharm Assoc"},{"key":"13962_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.japh.2017.03.014","volume":"57","author":"EL Dobson","year":"2017","unstructured":"Dobson EL, Klepser ME, Pogue JM, Labreche MJ, Adams AJ, Gauthier TP, et al. Outpatient antibiotic stewardship: interventions and opportunities. J Am Pharm Assoc. 2017;57:464\u201373.","journal-title":"J Am Pharm Assoc"},{"key":"13962_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/wmh3.307","volume":"11","author":"N Homedes","year":"2019","unstructured":"Homedes N, Fugh-Berman A. Pharmacies and the pharmaceutical industry in Latin America. World Med Health Policy. 2019;11:188\u2013202.","journal-title":"World Med Health Policy"},{"key":"13962_CR6","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.sapharm.2020.03.015","volume":"17","author":"CA Cadogan","year":"2021","unstructured":"Cadogan CA, Hughes CM. On the frontline against COVID-19: community pharmacists\u2019 contribution during a public health crisis. Res Soc Adm Pharm. 2021;17:2032\u20135.","journal-title":"Res Soc Adm Pharm"},{"key":"13962_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.sapharm.2020.02.003","volume":"16","author":"COL Ung","year":"2020","unstructured":"Ung COL. Community pharmacist in public health emergencies: quick to action against the coronavirus 2019-nCoV outbreak. Res Soc Adm Pharm. 2020;16:583\u20136.","journal-title":"Res Soc Adm Pharm"},{"key":"13962_CR8","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.sapharm.2020.07.003","volume":"17","author":"MB Visacri","year":"2021","unstructured":"Visacri MB, Figueiredo IV, de Lima TM. Role of pharmacist during the COVID-19 pandemic: a scoping review. Res Soc Adm Pharm. 2021;17:1799\u2013806.","journal-title":"Res Soc Adm Pharm"},{"key":"13962_CR9","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.sapharm.2020.03.012","volume":"17","author":"S Zheng","year":"2021","unstructured":"Zheng S, Yang L, Zhou P, Li H, Liu F, Zhao R. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Soc Adm Pharm. 2021;17:1819\u201324.","journal-title":"Res Soc Adm Pharm"},{"key":"13962_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.sapharm.2017.04.012","volume":"14","author":"DG Klepser","year":"2018","unstructured":"Klepser DG, Klepser ME, Smith JK, Dering-Anderson AM, Nelson M, Pohren LE. Utilization of influenza and streptococcal pharyngitis point-of-care testing in the community pharmacy practice setting. Res Soc Adm Pharm. 2018;14:356\u20139.","journal-title":"Res Soc Adm Pharm"},{"key":"13962_CR11","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.5688\/ajpe7218","volume":"83","author":"SL Haack","year":"2019","unstructured":"Haack SL, Mazar I, Carter EM, Addo-Atuah J, Ryan M, Salazar Preciado LL, et al. Cultural sensitivity and global pharmacy engagement in Latin America: Argentina, Brazil, Ecuador, Guatemala, and Mexico. Am J Pharm Educ. 2019;83:7218.","journal-title":"Am J Pharm Educ"},{"key":"13962_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4236\/pp.2020.119019","volume":"11","author":"MJ Hasan","year":"2020","unstructured":"Hasan MJ, Nead J. The pandemic COVID-19 and the auspicious role of frontier pharmacists against this global threat. PP. 2020;11:209\u201325.","journal-title":"PP"},{"key":"13962_CR13","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.sapharm.2020.04.013","volume":"17","author":"EW Hedima","year":"2021","unstructured":"Hedima EW, Adeyemi MS, Ikunaiye NY. Community pharmacists: on the frontline of health service against COVID-19 in LMICs. Res Soc Adm Pharm. 2021;17:1964\u20136.","journal-title":"Res Soc Adm Pharm"},{"key":"13962_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40267-020-00717-x","volume":"36","author":"Z Khan","year":"2020","unstructured":"Khan Z, Muhammad K, Ahmed A, Rahman H. Coronavirus outbreaks: prevention and management recommendations. Drugs Ther Perspect. 2020;36:215\u20137.","journal-title":"Drugs Ther Perspect"},{"key":"13962_CR15","volume-title":"Guatemala Analisis del sistema de salud, 2015","author":"C Avila","year":"2015","unstructured":"Avila C, Rhea B, Gutierrez JC, Hoadly K, Coite M, Romero N, et al. Guatemala Analisis del sistema de salud, 2015. Bethesda: Proyecto Health Fianance and Governance, Abt Associates Inc.; 2015."},{"key":"13962_CR16","doi-asserted-by":"publisher","unstructured":"Ramay BM, Lambour P, Cer\u00f3n A. Comparing antibiotic self-medication in two socio-economic groups in Guatemala City: a descriptive cross-sectional study. BMC Pharmacol Toxicol. 2015;16:11. https:\/\/doi.org\/10.1186\/s40360-015-0011-3.","DOI":"10.1186\/s40360-015-0011-3"},{"key":"13962_CR17","unstructured":"Ministerio de Salud Publica y Asistencia Social. Manual de normas de atencion en salud integral para primero y segundo nivel. Guatemala; 2012."},{"key":"13962_CR18","volume-title":"Recommendations for management of common childhood conditions: newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Recommendations for management of common childhood conditions: newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care. Geneva: World Health Organization; 2012."},{"key":"13962_CR19","volume-title":"Operational guidelines for intensified national SARI surveillance, 2011","author":"Pan American Health Organization","year":"2011","unstructured":"Pan American Health Organization. Operational guidelines for intensified national SARI surveillance, 2011. 2011."},{"key":"13962_CR20","unstructured":"World Health Organization. Global epidemiological surveillance standards for influenza. Geneva: World Health Organization; 2013. ISBN: 978 92 4 150660 1."},{"key":"13962_CR21","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.11118\/actaun201361061785","volume":"61","author":"I Manga","year":"2013","unstructured":"Manga I, Vylet\u011blov\u00e1 M. A new real-time PCR assay for rapid identification of the S. aureus\/MRSA strains. Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis. 2013;61:1785\u201392.","journal-title":"Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis"},{"key":"13962_CR22","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1128\/JCM.00795-11","volume":"49","author":"GE Fosheim","year":"2011","unstructured":"Fosheim GE, Nicholson AC, Albrecht VS, Limbago BM. Multiplex real-time PCR assay for detection of methicillin-resistant Staphylococcus aureus and associated toxin genes. J Clin Microbiol. 2011;49:3071\u20133.","journal-title":"J Clin Microbiol"},{"key":"13962_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.mimet.2006.09.003","volume":"68","author":"LC Thomas","year":"2007","unstructured":"Thomas LC, Gidding HF, Ginn AN, Olma T, Iredell J. Development of a real-time Staphylococcus aureus and MRSA (SAM-) PCR for routine blood culture. J Microbiol Methods. 2007;68:296\u2013302.","journal-title":"J Microbiol Methods"},{"key":"13962_CR24","volume-title":"Ministerio de trabajo y prevenci\u00f3n social","author":"Ministro de trabajo y prevencion social","year":"2022","unstructured":"Ministro de trabajo y prevencion social. Ministerio de trabajo y prevenci\u00f3n social. 2022. https:\/\/www.mintrabajo.gob.gt\/index.php\/leyes-y-convenios\/30."},{"key":"13962_CR25","volume-title":"Stata statistical software: release 15","author":"Stata Corp","year":"2017","unstructured":"Stata Corp. Stata statistical software: release 15. College Station: StataCorp LLC; 2017."},{"key":"13962_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2471\/BLT.11.090209","volume":"90","author":"E Azziz-Baumgartner","year":"2012","unstructured":"Azziz-Baumgartner E, Alamgir A, Rahman M, Homaira N, Sohel BM, Sharker MY, et al. Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008\u20132010. Bull World Health Organ. 2012;90:12\u20139.","journal-title":"Bull World Health Organ"},{"key":"13962_CR27","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/cid\/cix565","volume":"65","author":"YO Tinoco","year":"2017","unstructured":"Tinoco YO, Azziz-Baumgartner E, Uyeki TM, R\u00e1zuri HR, Kasper MR, Romero C, et al. Burden of influenza in 4 ecologically distinct regions of Peru: household active surveillance of a community cohort, 2009\u20132015. Clin Infect Dis. 2017;65:1532\u201341.","journal-title":"Clin Infect Dis"},{"key":"13962_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/003335491312800310","volume":"128","author":"K Seib","year":"2013","unstructured":"Seib K, Gleason C, Richards JL, Chamberlain A, Andrews T, Watson L, et al. Partners in Immunization: 2010 survey examining differences among H1N1 vaccine providers in Washington state. Public Health Rep. 2013;128:198\u2013211.","journal-title":"Public Health Rep"},{"key":"13962_CR29","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.sapharm.2020.04.002","volume":"17","author":"M Aruru","year":"2021","unstructured":"Aruru M, Truong H-A, Clark S. Pharmacy emergency preparedness and response (PEPR): a proposed framework for expanding pharmacy professionals\u2019 roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Res Soc Adm Pharm. 2021;17:1967\u201377.","journal-title":"Res Soc Adm Pharm"},{"key":"13962_CR30","doi-asserted-by":"publisher","first-page":"e47540","DOI":"10.1371\/journal.pone.0047540","volume":"7","author":"E Azziz-Baumgartner","year":"2012","unstructured":"Azziz-Baumgartner E, Cabrera AM, Chang L, Calli R, Kusznierz G, Baez C, et al. Mortality, severe acute respiratory infection, and influenza-like illness associated with influenza a(H1N1)pdm09 in Argentina, 2009. Plos One. 2012;7:e47540.","journal-title":"Plos One"},{"key":"13962_CR31","doi-asserted-by":"publisher","first-page":"e00373","DOI":"10.1128\/JCM.00373-19","volume":"57","author":"BA Pinsky","year":"2019","unstructured":"Pinsky BA, Hayden RT. Cost-effective respiratory virus testing. J Clin Microbiol. 2019;57:e00373\u201319 \/jcm\/57\/9\/JCM.00373-19.atom.","journal-title":"J Clin Microbiol"},{"key":"13962_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/ijpp.12488","volume":"26","author":"ME Klepser","year":"2018","unstructured":"Klepser ME, Adams AJ. Pharmacy-based management of influenza: lessons learned from research. Int J Pharm Pract. 2018;26:573\u20138.","journal-title":"Int J Pharm Pract"},{"key":"13962_CR33","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11096-020-01078-1","volume":"42","author":"K Hoti","year":"2020","unstructured":"Hoti K, Jakupi A, Hetemi D, Raka D, Hughes J, Desselle S. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists\u2019 experiences with preventative measures and sources of information. Int J Clin Pharm. 2020;42:1197\u2013206.","journal-title":"Int J Clin Pharm"},{"key":"13962_CR34","doi-asserted-by":"publisher","first-page":"200317","DOI":"10.5888\/pcd17.200317","volume":"17","author":"MA Strand","year":"2020","unstructured":"Strand MA, Bratberg J, Eukel H, Hardy M, Williams C. Community pharmacists\u2019 contributions to disease management during the COVID-19 pandemic. Prev Chronic Dis. 2020;17:200317.","journal-title":"Prev Chronic Dis"},{"key":"13962_CR35","doi-asserted-by":"publisher","first-page":"e6118","DOI":"10.1371\/journal.pone.0006118","volume":"4","author":"VA Laguna-Torres","year":"2009","unstructured":"Laguna-Torres VA, G\u00f3mez J, Oca\u00f1a V, Aguilar P, Saldarriaga T, Chavez E, et al. Influenza-Like Illness Sentinel Surveillance in Peru. Plos One. 2009;4:e6118.","journal-title":"Plos One"},{"key":"13962_CR36","first-page":"136","volume":"43","author":"A Ahaghaghi","year":"2014","unstructured":"Ahaghaghi A, Asadi M, Allahverdipour H. Predictors of self-medication behavior: a systematic review. Iranian J Publ Health. 2014;43:136\u201346.","journal-title":"Iranian J Publ Health"},{"key":"13962_CR37","doi-asserted-by":"publisher","unstructured":"Nepal G, Bhatta S. Self-medication with antibiotics in WHO southeast Asian region: a systematic review. Cureus. 2018. https:\/\/doi.org\/10.7759\/cureus.2428.","DOI":"10.7759\/cureus.2428"},{"key":"13962_CR38","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1353\/hpu.2021.0167","volume":"32","author":"EL Svenson","year":"2021","unstructured":"Svenson EL, Tun R, Conway JH, Legenza L, Svenson JM, Duffy S, et al. A one health approach to compare self-prescribed antibiotic use across rural and semi-urban populations in San Lucas Tolim\u00e1n, Guatemala. J Health Care Poor Underserved. 2021;32:1798\u2013817.","journal-title":"J Health Care Poor Underserved"},{"key":"13962_CR39","first-page":"2","volume":"79","author":"NF Torres","year":"2021","unstructured":"Torres NF, Chibi B, Kuupiel D, Solomon VP, Mashamba-Thompson TP, Middleton LE. The use of non-prescribed antibiotics; prevalence estimates in low-and-middle-income countries. A systematic review and meta-analysis. Arch. Public Health. 2021;79:2.","journal-title":"Public Health"},{"key":"13962_CR40","volume-title":"Availability of over-the-counter antibiotics in Guatemalan corner stores. Under review by the Journal of the Pan American Health Organization","author":"P Moreno","year":"2020","unstructured":"Moreno P, Ceron A, Sosa K, Morales M, Grajeda L, Lopez M, et al. Availability of over-the-counter antibiotics in Guatemalan corner stores. Under review by the Journal of the Pan American Health Organization. 2020."},{"key":"13962_CR41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1128\/AAC.02067-13","volume":"58","author":"H Li","year":"2014","unstructured":"Li H, Liu D-H, Chen L-L, Zhao Q, Yu Y-Z, Ding J-J, et al. Meta-analysis of the adverse effects of long-term azithromycin use in patients with chronic lung diseases. Antimicrob Agents Chemother. 2014;58:511\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"13962_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout JD, Laupland KB. Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159\u201366.","journal-title":"Lancet Infect Dis"},{"key":"13962_CR43","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","volume":"6","author":"A Versporten","year":"2018","unstructured":"Versporten A, Zarb P, Caniaux I, Gros M-F, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6:e619\u201329.","journal-title":"Lancet Glob Health"},{"key":"13962_CR44","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1016\/S2542-5196(18)30186-4","volume":"2","author":"P Collignon","year":"2018","unstructured":"Collignon P, Beggs JJ, Walsh TR, Gandra S, Laxminarayan R. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. Lancet Planet Health. 2018;2:e398\u2013405.","journal-title":"Lancet Planet Health"},{"key":"13962_CR45","volume-title":"No time to wait: securing the future from drug-resistant infections","author":"Secretary-General of the United Nations","year":"2019","unstructured":"Secretary-General of the United Nations. No time to wait: securing the future from drug-resistant infections. 2019. https:\/\/www.who.int\/antimicrobial-resistance\/interagency-coordination-group\/IACG_final_report_EN.pdf?ua=1."},{"key":"13962_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1744-8603-8-22","volume":"8","author":"A Anson","year":"2012","unstructured":"Anson A, Ramay B, Ruiz A, Bero L. Availability, prices and affordability of the World Health Organization\u2019s essential medicines for children in Guatemala. Glob Health. 2012;8:22.","journal-title":"Glob Health"},{"key":"13962_CR47","doi-asserted-by":"publisher","unstructured":"Flood D, Mathieu I, Chary A, et al. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff. BMC Health Serv Res. 2017;17:27. https:\/\/doi.org\/10.1186\/s12913-017-1991-z.","DOI":"10.1186\/s12913-017-1991-z"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13962-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13962-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T02:03:52Z","timestamp":1660356232000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13962-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13962"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13962-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with all applicable local regulatory requirements and the principles of the Declaration of Helsinki. Protocol number 171\u201309-2017 and the study was approved by the Universidad del Valle, Center for Health Studies (UVG- CHS) Ethics Research committee. Study personnel, including 5 physicians and 1 pharmacist were trained to carry out consent, data and sample collection prior to initiating the study. All adult participants provided written informed consent, participants 7\u201317\u2009years old provided informed assent, and parents\/guardians provided informed consent for participants 7\u201317\u2009years old.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1541"}}